CYP17A1 and metabolic dysfunction-associated steatotic liver disease: Our previous work revealed that hepatic 17-hydroxyprogesterone (17-OHP) concentrations were increased in NAFLD due to aberrant expression of cytochrome P450 17A1 (CYP17A1).